Vaccine composition

Details for Australian Patent Application No. 2006245920 (hide)

Owner Glaxo Group Limited

Inventors Ertl, Peter Franz; Tite, John Philip; Van Wely, Catherine Ann

Agent Shelston IP

Pub. Number AU-A-2006245920

PCT Pub. Number WO2006/120034

Priority 60/680,389 12.05.05 US

Filing date 10 May 2006

Wipo publication date 16 November 2006

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/120034 Priority application(s): WO2006/120034

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006245921-Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate

2006245916-Erythropoietin variants